| 1 |
23087017 | High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression. | 2013 Jan 1 |
1 |
| 2 |
21535409 | Ramiprilate inhibits functional matrix metalloproteinase activity in Crohn's disease fistulas. | 2011 Sep |
1 |
| 3 |
18399693 | Accurate aqueous proton dissociation constants calculations for selected angiotensin-converting enzyme inhibitors. | 2008 Jun |
1 |
| 4 |
16220025 | Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells. | 2006 |
2 |
| 5 |
16398929 | Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat. | 2006 Jan 6 |
1 |
| 6 |
15569856 | Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. | 2005 Jan |
3 |
| 7 |
16088213 | ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression. | 2005 Sep-Oct |
3 |
| 8 |
14615289 | Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells. | 2004 Jan 9 |
4 |
| 9 |
15530425 | ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression. | 2004 Dec 10 |
1 |
| 10 |
15601445 | Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors. | 2004 Dec |
2 |
| 11 |
14727938 | Spotlight on ramipril in the prevention of cardiovascular outcomes. | 2003 |
2 |
| 12 |
12076194 | Ramipril: a review of its use in the prevention of cardiovascular outcomes. | 2002 |
2 |
| 13 |
12361743 | Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma. | 2002 Nov 5 |
1 |
| 14 |
12381651 | Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. | 2002 Nov |
3 |
| 15 |
10209009 | Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells. | 1999 Apr 20 |
2 |
| 16 |
7768254 | Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. | 1995 |
1 |
| 17 |
8963479 | Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements. | 1995 Dec |
4 |
| 18 |
7515323 | Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells. | 1994 Feb 28 |
2 |
| 19 |
8137599 | Clinical pharmacokinetics of ramipril. | 1994 Jan |
1 |
| 20 |
8276048 | Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study. | 1993 |
2 |
| 21 |
8388656 | Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. | 1993 May |
1 |
| 22 |
1335341 | Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues. | 1992 Nov |
2 |
| 23 |
1646621 | A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects. | 1991 Feb |
1 |
| 24 |
1650862 | [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells]. | 1991 |
1 |
| 25 |
1663586 | Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. | 1991 Jul |
1 |
| 26 |
2147879 | Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications. | 1990 |
2 |
| 27 |
2474098 | High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli. | 1989 |
3 |
| 28 |
2474102 | Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV). | 1989 |
1 |
| 29 |
2474105 | Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure. | 1989 |
1 |
| 30 |
2483429 | The renin-angiotensin system and ramipril, a new converting enzyme inhibitor. | 1989 |
1 |
| 31 |
2831105 | Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril. | 1988 Apr |
2 |
| 32 |
2849453 | High affinity binding of ramiprilat on isolated human glomeruli. | 1988 Dec 15 |
3 |
| 33 |
2485060 | Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat. | 1987 |
6 |
| 34 |
3034032 | Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers. | 1987 Apr 24 |
1 |